. "327617" . "Mo\u017Enosti a meze psychoterapie u bipol\u00E1rn\u00ED poruchy" . . . . . . . "1212-0383" . "RIV/00023752:_____/09:00001200" . "2"^^ . "2" . "1"^^ . "CZ - \u010Cesk\u00E1 republika" . "8"^^ . . "Mo\u017Enosti a meze psychoterapie u bipol\u00E1rn\u00ED poruchy"@cs . . "P(1M0517), S" . "105" . . "Possibilities and limits of psychotherapy in bipolar disorder"@en . "Mo\u017Enosti a meze psychoterapie u bipol\u00E1rn\u00ED poruchy"@cs . "L\u00E1talov\u00E1, K." . . "Mo\u017Enosti a meze psychoterapie u bipol\u00E1rn\u00ED poruchy" . "Pr\u016Fb\u011Bh bipol\u00E1rn\u00ED afektivn\u00ED poruchy je charakterizov\u00E1n \u010Dast\u00FDmi relapsy kter\u00E9 jsou st\u0159\u00EDd\u00E1ny remisemi. Z\u00E1kladem l\u00E9\u010Dby v\u0161ech forem BAP je farmakoterapie. A\u010Dkoli m\u00E1me k dispozici \u0159adu farmak, kter\u00E1 vykazuj\u00ED velmi dobr\u00FD tymostabiliza\u010Dn\u00ED efekt, dlouhodob\u011B se da\u0159\u00ED stabilizovat pouze okolo 60 % pacient\u016F. Navzdory pokrok\u016Fm ve farmakoterapii do jednoho roku od akutn\u00ED epizody zrelabuje 40 % pacient\u016F, 62 % do dvou let a 73 % do p\u011Bti let. Opakovan\u00E9 ataky nemoci pacient\u016Fm v\u00FDrazn\u011B naru\u0161uj\u00ED jejich ka\u017Edodenn\u00ED \u017Eivot, sl\u00E1bnou jejich psychosoci\u00E1ln\u00ED schopnosti a celkov\u011B se st\u00E1vaj\u00ED n\u00E1chyln\u011Bj\u0161\u00EDmi k dal\u0161\u00EDm relaps\u016Fm. Zd\u00E1 se, \u017Ee slibnou cestou je pro pos\u00EDlen\u00ED remise spojen\u00ED farmakoterapie s psychoterapi\u00ED nebo psychoedukac\u00ED. Mezi hlavn\u00ED c\u00EDle psychologick\u00FDch intervenc\u00ED u bipol\u00E1rn\u00EDch pacient\u016F pat\u0159\u00ED prevence relaps\u016F, \u00FAprava \u0161patn\u00FDch vzorc\u016F chov\u00E1n\u00ED a psychosoci\u00E1ln\u00EDch funkc\u00ED. V\u00FDsledky randomizovan\u00FDch pokus\u016F s psychosoci\u00E1ln\u00EDmi intervencemi: psychoedukac\u00ED, rodinnou terapi\u00ED, kognitivn\u00ED terapi\u00ED a terapi\u00ED interperson\u00E1ln\u00EDch rytm\u016F potvrzuj\u00ED, \u017Ee tyto p\u0159\u00EDstupy posiluj\u00ED stabiliza\u010Dn\u00ED efekt farmak." . . . "Pra\u0161ko, J\u00E1n" . . . "http://www.cspsychiatr.cz/dwnld/CSP_2009_2_71_78.pdf" . "\u010Cesk\u00E1 a slovensk\u00E1 psychiatrie" . "Bipolar affective disorder runs a natural course of frequent relapses and recurrences. Treatment of the illness has consisted mainly of pharmacotherapy however, we have many drugs with good mood stabilizing effect, only about 60% of patient are stabilizated for long term period. Despite considerable advances in pharmacotherapy, about 40% of patients with bipolar disorder are reported to relapse within 1 year, 60% over 2 years and 73% over 5 years. Repeated recurrent episodes are highly disruptive to the patients' functioning in everyday life, with such poor psychosocial capacity itself becoming a vulnerability factor for more frequent relapses. One of the promising way how to enhance stability of remission seems to be combination pharmacotherpapy and psychoeducation or psychotherapy. The main challenges for psychological treatments for bipolar disorder are preventing relapse, modyfying dysfunctional attitudes, and improving psychosocial functioning. Randomized controlled trials of psychosocial interventions, such as psychoeducation, family intervention, cognitive therapy and therapy of interpersonal rhythms indicate that these approaches augment stabilizing effect of drug treatment."@en . "[3EFCD58BE7D2]" . "Possibilities and limits of psychotherapy in bipolar disorder"@en . . . . . "bipolar affective disorder; psychotherapy; psychoeducation; cognitive therapy; therapy of interpersonal rhythms; family therapy"@en . "Pr\u016Fb\u011Bh bipol\u00E1rn\u00ED afektivn\u00ED poruchy je charakterizov\u00E1n \u010Dast\u00FDmi relapsy kter\u00E9 jsou st\u0159\u00EDd\u00E1ny remisemi. Z\u00E1kladem l\u00E9\u010Dby v\u0161ech forem BAP je farmakoterapie. A\u010Dkoli m\u00E1me k dispozici \u0159adu farmak, kter\u00E1 vykazuj\u00ED velmi dobr\u00FD tymostabiliza\u010Dn\u00ED efekt, dlouhodob\u011B se da\u0159\u00ED stabilizovat pouze okolo 60 % pacient\u016F. Navzdory pokrok\u016Fm ve farmakoterapii do jednoho roku od akutn\u00ED epizody zrelabuje 40 % pacient\u016F, 62 % do dvou let a 73 % do p\u011Bti let. Opakovan\u00E9 ataky nemoci pacient\u016Fm v\u00FDrazn\u011B naru\u0161uj\u00ED jejich ka\u017Edodenn\u00ED \u017Eivot, sl\u00E1bnou jejich psychosoci\u00E1ln\u00ED schopnosti a celkov\u011B se st\u00E1vaj\u00ED n\u00E1chyln\u011Bj\u0161\u00EDmi k dal\u0161\u00EDm relaps\u016Fm. Zd\u00E1 se, \u017Ee slibnou cestou je pro pos\u00EDlen\u00ED remise spojen\u00ED farmakoterapie s psychoterapi\u00ED nebo psychoedukac\u00ED. Mezi hlavn\u00ED c\u00EDle psychologick\u00FDch intervenc\u00ED u bipol\u00E1rn\u00EDch pacient\u016F pat\u0159\u00ED prevence relaps\u016F, \u00FAprava \u0161patn\u00FDch vzorc\u016F chov\u00E1n\u00ED a psychosoci\u00E1ln\u00EDch funkc\u00ED. V\u00FDsledky randomizovan\u00FDch pokus\u016F s psychosoci\u00E1ln\u00EDmi intervencemi: psychoedukac\u00ED, rodinnou terapi\u00ED, kognitivn\u00ED terapi\u00ED a terapi\u00ED interperson\u00E1ln\u00EDch rytm\u016F potvrzuj\u00ED, \u017Ee tyto p\u0159\u00EDstupy posiluj\u00ED stabiliza\u010Dn\u00ED efekt farmak."@cs . "RIV/00023752:_____/09:00001200!RIV12-MSM-00023752" .